Vnitr Lek 2008, 54(3):257-264
Von Willebrand disease
- Oddělení klinické hematologie FN Brno, pracoviště Bohunice, prim. prof. MUDr. Miroslav Penka, CSc.
Von Willebrand disease is the most spread hereditary bleeding disorder with prevalence up to the 1 % in the population. Haemorrhagic symptoms are various intensity, mostly not severe. A large part of affected patients do not come to see a doctor. However these patients are potentially endangered by a serious haemorrhage after a trauma, surgery or during another illness. The estimated number of patients with von Willebrand disease is 1,500-3,500 per 1,000,000 of population; the number of persons with symptomatic von Willebrand disease was estimated to be at least 100 per million. This disease deserves attention not only by haematologists but other physicians too. In our communication we present short overview about von Willebrand disease: there are briefly described pathophysiology, classification, diagnosis and treatment of this illness.
Keywords: von Willebrand factor; von Willebrand disease; classification; diagnosis; treatment
Received: December 10, 2007; Accepted: January 13, 2008; Published: March 1, 2008 Show citation
References
- Sadler JE, Budde U, Eikenboom JC et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-2114.
Go to original source...
Go to PubMed...
- Ginsburg D, Bowie EJW. Molecular genetics of von Willebrand disease. Blood 1992; 79: 2507-2519.
Go to original source...
- Holmberg L, Nilsson M. Von Willebrand's disease. Eur J Haematol 1992; 48: 127-141.
Go to original source...
Go to PubMed...
- Miller JL. Von Willebrand disease. Hematom/Oncol Clin North Am 1990; 4: 107-127.
Go to original source...
Go to PubMed...
- Schneppenheim R. Hämostaseologishe und molekulare Diagnostik des Von-Willebrand-Syndroms. Hämostaseologie 1994; 14: 159-169.
Go to original source...
- Murray EW. Von Willebrand disease: Pathogenesis, classification and management. Transf Med Rev 1996; 10: 93-110.
Go to original source...
Go to PubMed...
- Lyons SE, Ginsburg D. Molecular and cellular biology of von Willebrand factor. Trends Cardiovasc Med 1994; 4: 34-39.
Go to original source...
Go to PubMed...
- Sadler JE, Mannucci PM, Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-174.
Go to original source...
Go to PubMed...
- Eikenboom JC, Reitsma PH, Briët E. The inheritance and molecular genetics of von Willebranďs disease. Haemophilia 1995; 1: 77-90.
Go to original source...
Go to PubMed...
- http://www.med.unc.edu/isth/SSC/99minutes/toc99.htm
- Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-525.
Go to original source...
Go to PubMed...
- James PD, Notley C, Hegadorn C et al. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood 2007; 109: 145-154.
Go to original source...
Go to PubMed...
- Goodeve A, Einkenboom J, Castaman G et al. Phenotype and genotype of a cohort of families historically diagnose with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1 VWD). Blood 2007; 109: 112-121.
Go to original source...
Go to PubMed...
- Lee CA, Berntorp EE, Hoots WK. Textbook of Hemophilia. 1. ed. Oxford: Blackwell Publishing 2005.
Go to original source...
- Zimmerman TS, Ruggeri ZM. Von Willebranďs disease. Clin Haematol 1983; 12: 175-199.
Go to original source...
- Budde U, Drewke E, Mainusch K et al. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost 2002; 28: 173-190.
Go to original source...
Go to PubMed...
- Ginsburg D. Molecular genetics of von Willebrand disease. Thromb Haemost 1999; 82: 585-591.
Go to original source...
Go to PubMed...
- Veyradier A, Jenkins ChSP, Fressinaud E et al. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost 2000; 84: 175-182.
Go to original source...
Go to PubMed...
- Eikenboom JC, Van der Meer FJM, Briet E. Acquired von Willebranďs disease due to excessive fibrinolysis. Br J Haematol 1992; 81: 618-620.
Go to original source...
Go to PubMed...
- Jakway JL. Acquired von Willebrand s disease. Hematom/Oncol Clin North Am 1992; 6: 1409-1420.
Go to original source...
- Warkentin TE, Moore JC, Morgan DG. Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebranďs disease the link? Lancet 1992; 340: 35-37.
Go to original source...
Go to PubMed...
- Kreuz W, Linde R, Funk M et al. Valproate therapy induces von Willebrand disease type I. Epilepsia 1992; 33: 178-184.
Go to original source...
Go to PubMed...
- Federici AB, Castaman G, Mannucci PM et al. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8: 607-621.
Go to original source...
Go to PubMed...
- Federici AB, Mannucci PM. Diagnosis and management of von Willebrand disease. Haemophilia 1999; 5(Suppl 2): 28-37.
Go to original source...
Go to PubMed...
- Dean JA, Blanchette VS, Carcao MD et al. von Willebrand disease in a pediatric based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-89.
Go to original source...
Go to PubMed...
- Ingerslev J, Gürsel T. Diagnosis of von Willebrand disease. Haemophilia 1999; 5(Suppl 2): 50-56.
Go to original source...
Go to PubMed...
- Favaloro EJ, Smith J, Petinos P et al. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in haematology haemostasis scientific advisory panel. Thromb Haemost 1999; 82: 1276-1282.
Go to original source...
Go to PubMed...
- Vanhoorelbeke K, Cauwenberghs N, Vauterin S et al. A Reliable and Reproducible ELISA Metod to Measure Ristocetin Cofactor Aktivity of von Willebrand Factor. Throbm Haemost 2000; 83:107-113.
Go to original source...
- Vanhoorelbeke K, Pareyn I, Schlammadinger A et al. Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA. Throbm Haemost 2005; 93: 165-171.
Go to original source...
Go to PubMed...
- Favaloro EJ. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Blood Reviews 1999; 13: 185-204.
Go to original source...
Go to PubMed...
- Favaloro EJ. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Am J Clin Pathol 2000; 114: 608-618.
Go to original source...
Go to PubMed...
- Riddell AF, Jenkins PV, Nitu-Whalley IC et al. Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay. Br J Haemat 2002; 116: 187-192.
Go to original source...
Go to PubMed...
- Turek P, Sikorová J, Vorlová Z. Stanovení von Willebrandova faktoru. Vnitř Lék 1984; 30: 550-556.
Go to PubMed...
- Habart D. Von Willebrandova choroba typu 2N (Normandy). Vnitř Lék 2003; 49: 253-255.
- Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of vWD type 1. J Thromb Haemost 2005; 3: 775-777.
Go to original source...
Go to PubMed...
- Kadir RA, Economides DL, Sabin CA et al. Variations in coagulation factor in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82: 1456-1461.
Go to original source...
Go to PubMed...
- Levy G, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 2001; 86: 144-148.
Go to original source...
Go to PubMed...
- Mannucci PM Desmopressin (DDAVP) in the treatment of bleeding disorders: the First 20 Years. Blood 1997; 90: 2515-2521.
Go to original source...
- Mannucci PM. Treatment of von Willebrand disease. Thromb Haemost 2001; 86: 149-153.
Go to original source...
Go to PubMed...
- Mazurier C, Guacher Ch, Jorieux S et al. Biological effect of desmopressin in eight patients with type 2N (Normandy) von Willebrand disease. Br J Haematol 1994; 88: 849-854.
Go to original source...
Go to PubMed...
- Pasi KJ, Collins PW, Keeling DM et al. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004; 10: 218-231.
Go to original source...
Go to PubMed...
- Chang AC, Rick ME, Pierce LR et al. Summary of a workshop on potency and dosage of von Willebrand factor concentrates. Haemophilia 1998; 4(Suppl 3): 1-6.
Go to original source...
Go to PubMed...
- Berntorp E. Von Willebrand factor containing factor VIII concentrates. Haemophilia 1999; 5(Suppl 2): 60-63.
Go to original source...
Go to PubMed...
- Federici AB, Castaman G, Thompson A et al. Von Willebrand's disease: clinical management. Haemophilia 2006; 12 (Suppl 3): 152-158.
Go to original source...
Go to PubMed...
- Goudemand J, Scharrer I, Berntorp E et al. Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods. J Thromb Haemost 2005; 3: 2219-2227.
Go to original source...
Go to PubMed...
- Berntorp E. Plasma product treatment in various types of von Willebrand's disease. Haemostasis 1994; 24: 289-297.
Go to original source...
Go to PubMed...
- Ramsahoye BH, Davies SV, Dasani H et al. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 1: 140-144.
Go to original source...
Go to PubMed...